IBEX Ltd Chief People Officer Inson Paul Joseph sold 2,274 shares at $40 per share on September 14, 2026. The transaction represented about 7.1% of his prior IBEX holding, while Joseph retained 29,724 shares afterward, giving investors the reported size of the sale and his remaining position.
Key Highlights
- Inson Paul Joseph held 29,724 IBEX Ltd shares after the transaction.
- The transaction occurred on 14 September 2026.
- The sale represented about 7.1% of Joseph’s prior shareholding.
IBEX Ltd (NASDAQ: IBEX) Chief People Officer Inson Paul Joseph sold 2,274 shares at $40 per share. The transaction took place on 14 September 2026.
Joseph Retains 29,724 IBEX Shares
Joseph’s position after the transaction stood at 29,724 IBEX Ltd shares. The reported transaction carries code S. The post-transaction balance identifies the number of IBEX shares he continued to own after the sale.
Sale Equalled About 7.1% Of Prior Holding
The transaction represented about 7.1% of Joseph’s prior shares holding in IBEX Ltd. The percentage is based on Joseph’s prior shareholding in IBEX Ltd. Joseph’s reported holding after the transaction was 29,724 shares.
FAQs
Q: How many IBEX shares did Inson Paul Joseph sell?
A: Inson Paul Joseph sold 2,274 IBEX Ltd shares at $40 per share on 14 September 2026. The filing identifies the transaction with code S.
Q: How many IBEX shares did Joseph own after the sale?
A: Inson Paul Joseph owned 29,724 IBEX Ltd shares after the transaction. The figure represents his reported post-transaction holding in the filing.
Q: What percentage of Joseph’s IBEX holding did the sale represent?
A: The transaction represented about 7.1% of Inson Paul Joseph’s prior shareholding in IBEX Ltd. The percentage applies to his own position.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.